Ornidazole-¹³C₂,¹⁵N₂  (Synonyms: 奥硝唑-¹³C₂,¹⁵N₂; Ro 7-0207-¹³C₂,¹⁵N₂)

Ornidazole-¹³C₂,¹⁵N₂ is the ¹³C, ¹⁵N labeled Ornidazole. Ornidazole(Ro 7-0207) is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria.

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

223.60

C₅¹³C₂H₁₀ClN¹⁵N₂O₃

奥硝唑-¹³C₂,¹⁵N₂；奥尼达唑-¹³C₂,¹⁵N₂；氯丙硝唑-¹³C₂,¹⁵N₂；氯甲硝咪唑-¹³C₂,¹⁵N₂；硝氯丙唑-¹³C₂,¹⁵N₂；氯醇硝唑-¹³C₂,¹⁵N₂

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.  [Content Brief]

  [2]. Rutgeerts, P., et al., Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology, 2005. 128(4): p. 856-61.  [Content Brief]

  [3]. Goldstein, E.J., V.L. Sutter, and S.M. Finegold, Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538. Antimicrob Agents Chemother, 1978. 14(4): p. 609-13.  [Content Brief]